Life Science Company News

Reset
Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Electrophysiology Market is expected to generate a revenue of USD 17.04 Billion by 2031, Globally, at 9.62% CAGR: Verified Market Research®

Read more ››
By: PR Newswire Association LLC. - 08 Oct 2024

Medical Imaging Equipment Services Market Poised for Significant Growth: Projected to Expand from USD 60 Billion in 2024 to USD 85 Billion by 2031: Market Research Intellect

Read more ››
By: PR Newswire Association LLC. - 08 Oct 2024

Peripheral Vascular Devices Market to Hit USD 14.73 Billion by 2029 with 5.2% CAGR | MarketsandMarkets™

Read more ››
By: PR Newswire Association LLC. - 08 Oct 2024

Safe Life Completes Acquisitions of SafetyMed and Enerspect in the US

Read more ››
By: PR Newswire Association LLC. - 08 Oct 2024

SKYLINEDX ANNOUNCES UPCOMING ORAL PRESENTATION AT THE 21ST INTERNATIONAL CONGRESS OF THE SOCIETY FOR MELANOMA RESEARCH

Read more ››
By: PR Newswire Association LLC. - 08 Oct 2024
Related companies:  SkylineDx BV

A Québec family-owned business acquires Formedica

Read more ››
By: PR Newswire Association LLC. - 08 Oct 2024
Related companies:  Formedica Ltée.

Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer

Read more ››
By: GlobeNewswire - 08 Oct 2024

23andMe Announces Mathew Knowles as New Brand Ambassador

Read more ››
By: GlobeNewswire - 08 Oct 2024
Related companies:  23andMe, Inc.

Opthea Appoints Chief Medical Officer and Chief Financial Officer as Company Prepares for Phase 3 Topline Data Readouts in 2025

Read more ››
By: GlobeNewswire - 08 Oct 2024
Related companies:  Opthea Limited

VitalHub Completes Acquisition of MedCurrent Corporation

Read more ››
By: GlobeNewswire - 08 Oct 2024
Related companies:  VitalHub Corp

KSQ Therapeutics Appoints Anna Truppel-Hartmann, M.D., as Chief Medical Officer

Read more ››
By: GlobeNewswire - 08 Oct 2024
Related companies:  KSQ Therapeutics, Inc.

Diagonal Therapeutics to Present at the Cure HHT’s 15th International Scientific Conference

Read more ››
By: GlobeNewswire - 08 Oct 2024
Related companies:  Diagonal Bio AB | Diagonal Therapeutics

Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

Read more ››
By: GlobeNewswire - 08 Oct 2024
Related companies:  Avantium N.V. | Avalo Therapeutics, Inc.

Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity

Read more ››
By: GlobeNewswire - 08 Oct 2024
Related companies:  Bio-Path Holdings, Inc.

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA

Read more ››
By: GlobeNewswire - 08 Oct 2024
Related companies:  Teva Pharmaceutical Industries Ltd

Avextra Announces the Approval of NEUROBIS by the Italian Medicines Agency: A Phase II Clinical Trial Using a Proprietary Cannabis-based Medicine for the Treatment of the Symptoms of Neurodegenerative Diseases

Read more ››
By: GlobeNewswire - 08 Oct 2024

Mestag Therapeutics Announces License and Research Collaboration with MSD to Identify Novel Targets for Inflammatory Diseases

Read more ››
By: GlobeNewswire - 08 Oct 2024

COSCIENS Biopharma Announces Change to Board of Directors

Read more ››
By: GlobeNewswire - 08 Oct 2024
Related companies:  COSCIENS Biopharma Inc.

New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA

Read more ››
By: GlobeNewswire - 08 Oct 2024
Related companies:  Biogen Inc.

Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil

Read more ››
By: GlobeNewswire - 08 Oct 2024
Related companies:  Traws Pharma, Inc.
Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »